Equities

Cutera Inc

Cutera Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.52
  • Today's Change0.12 / 8.57%
  • Shares traded451.28k
  • 1 Year change-89.76%
  • Beta1.3204
Data delayed at least 15 minutes, as of Jul 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.

  • Revenue in USD (TTM)196.64m
  • Net income in USD-157.56m
  • Incorporated1998
  • Employees430.00
  • Location
    Cutera Inc3240 Bayshore BlvdBRISBANE 94005-1021United StatesUSA
  • Phone+1 (415) 657-5500
  • Fax+1 (415) 330-2444
  • Websitehttps://www.cutera.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Meihua International Medical Tech Co Ltd97.10m11.63m25.96m617.002.100.16692.150.26740.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
Trinity Biotech plc (ADR)56.71m-33.88m27.07m380.00------0.4774-4.42-2.817.41-14.960.6251.693.67149,229.00-37.34-20.30-47.55-29.5434.2139.92-59.75-29.861.03-1.961.36---9.10-10.1515.41---31.08--
Holdco Nuvo Group DG Ltd0.00-3.49m28.21m----0.7798-----0.3581-0.35810.001.090.00-------2.34---2.40--------------0.00-------255.01------
Accelerate Diagnostics Inc12.17m-59.05m28.67m134.00------2.36-4.54-4.540.82-1.180.29782.055.2490,805.97-144.52-75.24---94.4628.3235.08-485.31-638.551.29--2.93---5.4316.291.40--0.7307--
Beyond Air Inc1.16m-60.24m29.15m107.00--1.16--25.15-1.83-1.830.0350.54570.01841.511.9310,831.78-102.29-78.25-145.94-99.91-112.77---5,547.37-6,152.993.61-55.710.3634-----31.57-7.93--152.05--
Cutera Inc196.64m-157.56m30.55m430.00------0.1554-7.89-7.899.86-9.600.48642.294.43457,293.00-38.97-22.00-50.24-30.7216.4247.63-80.13-27.242.22-43.941.84---15.865.47-97.76--85.87--
Positron Corp1.24m-1.27m30.66m22.00------24.79-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Spectral AI Inc19.30m-20.45m31.29m78.00------1.62-1.50-1.501.36-0.1161.30--9.42247,487.20-137.87---601.38--44.78---105.94--0.837--1.54---28.82---616.14------
bioAffinity Technologies Inc4.94m-8.37m31.59m75.00--5.78--6.40-0.9197-0.91970.54160.46870.5334318.228.7065,839.60-90.38---104.93--32.88---169.42--2.21--0.1782--52,660.42--2.66------
Know Labs Inc0.00-20.70m31.81m14.00---------0.3451-0.34510.00-0.02130.00----0.00-254.68-209.16-937.53-1,087.76-------1,302.62---23.611.47---100.00---1.85---3.64--
IRIDEX Corp49.92m-10.94m33.32m111.00--5.14--0.6674-0.6759-0.67593.080.39921.332.667.42449,765.80-29.16-19.54-47.74-27.4640.7242.67-21.92-15.451.03--0.00---8.964.02-26.81---24.35--
Harvard Apparatus Regenertv Tchnlgy Inc160.00k-8.08m33.66m10.00--187.41--210.39-0.5824-0.58240.01150.01260.0474----16,000.00-239.52-330.30-507.69-1,524.8877.50---5,053.13-35,138.840.2558--0.7407-------44.28---39.07--
Retractable Technologies Inc40.20m-7.80m33.83m148.00--0.3402--0.8416-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
iCAD Inc17.94m-5.14m33.97m67.00--1.04--1.89-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
Data as of Jul 26 2024. Currency figures normalised to Cutera Inc's reporting currency: US Dollar USD

Institutional shareholders

40.31%Per cent of shares held by top holders
HolderShares% Held
RTW Investments LPas of 31 Mar 20241.33m6.63%
BlackRock Fund Advisorsas of 31 Mar 20241.16m5.79%
Pura Vida Investments LLCas of 31 Mar 20241.08m5.37%
The Vanguard Group, Inc.as of 31 Mar 20241.00m5.00%
Findell Capital Management LLCas of 31 Mar 2024830.00k4.13%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 31 Mar 2024672.69k3.35%
Millennium Management LLCas of 31 Mar 2024569.96k2.84%
SSgA Funds Management, Inc.as of 31 Mar 2024503.93k2.51%
GAMCO Asset Management, Inc.as of 28 Jun 2024502.03k2.50%
Hawk Ridge Capital Management LPas of 31 Mar 2024444.91k2.21%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.